M&A Deal Summary |
|
---|---|
Date | 2024-05-15 |
Target | Single Use Support |
Sector | Packaging |
Buyer(s) | Novo Holdings A/S |
Sellers(s) | Pall |
Deal Type | Divestiture |
Advisor(s) | Jefferies (Financial) E+H Eisenberger + Herzog Rechtsanwalts (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Novo Holdings A/S is a Danish holding company and the investment arm of the Novo Nordisk Foundation. Novo Holdings' objective is to grow the assets of the Foundation and improve the lives of people around the world. In addition to investing in equity and fixed income securities, Novo Holdings pursues direct investments in life science companies. Novo Holdings A/S was established in 1999 and is headquartered in Hellerup, Denmark.
DEAL STATS | # |
---|---|
Overall | 14 of 14 |
Sector (Packaging) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Austria) | 1 of 1 |
Year (2024) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-02-05 |
Catalent
Somerset, New Jersey, United States Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey. |
Buy | $16.5B |
Category | Company |
---|---|
Founded | 1946 |
Sector | Manufacturing |
Employees | 10,400 |
Revenue | 2.8B USD (2014) |
Pall Corp. is a provider of filtration, separation and purification products to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry.
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Packaging) | 1 of 1 |
Type (Divestiture) | 3 of 3 |
Country (Austria) | 1 of 1 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-12-16 |
Single Use Support
Kufstein, Austria Single Use Support is a process solution provider specializing in fluid and cold chain management of drug substances. The company focuses on developing solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing, and cold chain shipping of advanced therapies and biologics in pharmaceutical production. Single Use Support Gmbh was founded in 2016 and is based in Kufstein, Germany. |
Buy | - |